Processing

Please wait...

Settings

Settings

1. WO1996005817 - MEDICAMENT FOR TREATMENT OR PROPHYLAXIS OF INCONTINENCE

Publication Number WO/1996/005817
Publication Date 29.02.1996
International Application No. PCT/GB1995/001995
International Filing Date 22.08.1995
IPC
A61K 31/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
A61K 31/438 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435having six-membered rings with one nitrogen as the only ring hetero atom
438the ring being spiro-condensed with carbocyclic or heterocyclic ring systems
A61K 31/506 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
495having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
506not condensed and containing further heterocyclic rings
CPC
A61K 31/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
A61K 31/438
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435having six-membered rings with one nitrogen as the only ring hetero atom
438The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
A61K 31/506
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
495having six-membered rings with two ; or more; nitrogen atoms as the only ring heteroatoms, e.g. piperazine ; or tetrazines
505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
506not condensed and containing further heterocyclic rings
Applicants
  • MEDINNOVA SF [NO/NO]; Rikshospitalet N-0027 Oslo, NO (AllExceptUS)
  • DZIEGLEWSKA, Hanna, Eva [GB/GB]; GB (GB)
  • MALT, Ulrik, Fredrik [NO/NO]; NO (UsOnly)
  • BLOMHOFF, Svein [NO/NO]; NO (UsOnly)
Inventors
  • MALT, Ulrik, Fredrik; NO
  • BLOMHOFF, Svein; NO
Agents
  • DZIEGLEWSKA, Hanna, Eva ; Frank B. Dehn & Co. Imperial House 15-19 Kingsway London WC2B 6UZ, GB
Priority Data
9417135.223.08.1994GB
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) MEDICAMENT FOR TREATMENT OR PROPHYLAXIS OF INCONTINENCE
(FR) MEDICAMENT DESTINE AU TRAITEMENT OU A LA PROPHYLAXIE DE L'INCONTINENCE
Abstract
(EN)
The present invention relates to the use of compounds which interact with 5-HT1A receptors, especially azapirones or pharmaceutically acceptable salts thereof, for the preparation of medicaments for use in the treatment or prophylaxis of incontinence disorders, methods of treatment using these compounds and pharmaceutical compositions containing these compounds.
(FR)
L'invention concerne l'utilisation de composés, ou de sels de ceux-ci acceptables sur le plan pharmacologique, interagissant avec des récepteurs de 5-HT1A, notamment des azapirones, dans la préparation de médicaments utiles dans le traitement ou la prophylaxie de l'incontinence. On décrit également de procédés de traitement à l'aide de ces composés ainsi que des compositions pharmaceutiques contenant ceux-ci.
Also published as
Latest bibliographic data on file with the International Bureau